Citigroup »

Fate Therapeutics shares owned by Citigroup

Quarter-by-quarter ownership of Fate Therapeutics (FATE) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Fate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Fate Therapeutics held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fate Therapeutics by Citigroup

Quarter filed Position value Share count Share price at filing
2024-03-31 $4.6M 623k 7.34
2023-12-31 $3.2M 844k 3.74
2023-09-30 $19k 8.7k 2.12
2023-03-31 $6.4M 1.1M 5.71
2022-12-31 $2.0M 196k 10.09
2022-09-30 $4.8M 229k 20.83
2021-12-31 $6.2M 107k 58.51
2021-03-31 $4.1M 56k 74.07
2020-12-31 $1.5M 20k 74.07
2020-09-30 $336k 8.4k 40.01
2020-06-30 $7.3M 214k 34.31
2020-03-31 $1.2M 53k 22.21
2019-12-31 $501k 26k 19.59
2019-09-30 $1.3M 88k 15.39
2019-06-30 $827k 41k 20.27
2019-03-31 $305k 17k 17.57
2018-12-31 $910k 71k 12.83
2018-09-30 $1.2M 76k 16.29
2018-06-30 $587k 52k 11.35
2018-03-31 $100k 10k 9.71
2017-12-31 $32k 5.2k 6.16
2017-09-30 $0 70 0.00
2017-06-30 $0 97 0.00
2017-03-31 $0 100 0.00
2015-06-30 $999 84 11.90
2014-09-30 $2.0k 395 5.06
2013-12-31 $0 47 0.00